PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $264,866 | -42.7% | 37,096 | -32.3% | 0.00% | 0.0% |
| Q2 2022 | $462,000 | +40.0% | 54,769 | +124.9% | 0.00% | 0.0% |
| Q1 2022 | $330,000 | -47.8% | 24,352 | -24.3% | 0.00% | 0.0% |
| Q4 2021 | $632,000 | -37.2% | 32,165 | +8.2% | 0.00% | -80.0% |
| Q2 2021 | $1,007,000 | -76.5% | 29,731 | -73.9% | 0.01% | -75.0% |
| Q1 2021 | $4,278,000 | +8.6% | 113,885 | -4.0% | 0.02% | -4.8% |
| Q4 2020 | $3,941,000 | – | 118,649 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 5,827,415 | $187,060,000 | 14.97% |
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $66,378,000 | 14.44% |
| Abingworth LLP | 1,203,135 | $38,512,000 | 8.74% |
| Penn Mutual Asset Management, LLC | 86,940 | $2,791,000 | 4.41% |
| GREAT POINT PARTNERS LLC | 220,863 | $7,090,000 | 1.65% |
| RA Capital Management | 3,115,008 | $99,992,000 | 1.39% |
| StepStone Group LP | 422,085 | $13,549,000 | 0.88% |
| Summit Rock Advisors, LP | 34,100 | $1,094,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 186,210 | $5,977,000 | 0.42% |
| Eventide Asset Management | 600,000 | $19,260,000 | 0.25% |